Glioblastoma in the elderly: Current and future trends

Critical Reviews in Oncology/Hematology

Volumn 60, Issue 3, 2006, Pages 256-266

  Brandes, Alba A ^a   Compostella, Alessia ^b   Blatt, Valeria ^b   Tosoni, Alicia ^b  

^a BELLARIA HOSPITAL   (Italy)

^b VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

Author keywords

Chemotherapy; Elderly; Glioblastoma; Radiotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; CARMUSTINE; CISPLATIN; ERLOTINIB; GEFITINIB; LOMUSTINE; PACLITAXEL; PROCARBAZINE; TEMOZOLOMIDE; VINCRISTINE;

AGING; BLOOD TOXICITY; BRAIN ATROPHY; CANCER CHEMOTHERAPY; CANCER EPIDEMIOLOGY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; COGNITIVE DEFECT; DEMENTIA; DIABETES MELLITUS; DRUG INDUCED DISEASE; DRUG TOLERABILITY; GLIOBLASTOMA; HUMAN; MULTIMODALITY CANCER THERAPY; NEUROSURGERY; NEUTROPENIA; PROGNOSIS; QUALITY OF LIFE; RADIATION DOSE; RADIATION INJURY; REVIEW; TREATMENT OUTCOME;

AGED; BRAIN NEOPLASMS; GLIOBLASTOMA; HUMANS; PROGNOSIS;

EID: 33750726760     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.critrevonc.2006.06.014     Document Type: Review

References (73)

1. Fleury A., Menegoz F., Grosclaude P., et al. Descriptive epidemiology of cerebral gliomas in France. Cancer 79 (1997) 1195-1202
2. Wymenga A.N., Slaets J.P., and Sleijfer D.T. Treatment of cancer in old age, shortcomings and challenges. Neth J Med 59 (2001) 259-266
3. Yancik R. Cancer burden in the aged: an epidemiologic and demographic overview. Cancer 80 (1997) 1273-1283
4. Curran Jr. W.J., Scott C.B., Horton J., et al. Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst 85 (1993) 704-710
5. Brandes A., and Fiorentino M.V. Treatment of high-grade gliomas in the elderly. Oncology 55 (1998) 1-6
6. Greig N.H., Ries L.G., Yancik R., and Rapoport S.I. Increasing annual incidence of primary malignant brain tumors in the elderly. J Natl Cancer Inst 82 (1990) 1621-1624
7. Jukich P.J., McCarthy B.J., Surawicz T.S., et al. Trends in incidence of primary brain tumors in the United States, 1985-1994. Neurooncology 3 (2001) 141-151
8. Riggs J.E. Rising primary malignant brain tumor mortality in the elderly. A manifestation of differential survival. Arch Neurol 52 (1995) 571-575
9. Kleihues P., and Webster K. World Health Organization (WHO) pathology and genetics of tumours of the nervous system (2000), IARC Press, Lyon, France
10. Scott C.B., Scarantino C., Urtasun R., et al. validation and predictive power of Radiation Therapy Oncology Group (RTOG) recursive partitioning analysis classes for malignant glioma patients: a report using RTOG 90-06. Int J Radiat Oncol Biol Phys 40 (1998) 51-55
11. Burger P.C., and Green S.B. Patient age, histologic features, and length of survival in patients with glioblastoma multiforme. Cancer 59 (1987) 1617-1625
12. Korshunov A., Sycheva R., and Golanov A. The prognostic relevance of molecular alterations in glioblastomas for patients age <50 years. Cancer 104 (2005) 825-832
13. Kunwar S., Mohapatra G., Bollen A., et al. Genetic subgroups of anaplastic astrocytomas correlate with patient age and survival. Cancer Res 61 (2001) 7683-7688
14. Batchelor T.T., Betensky R.A., Esposito J.M., et al. Age-dependent prognostic effects of genetic alterations in glioblastoma. Clin Cancer Res 10 (2004) 228-233
15. Simmons M.L., Lamborn K.R., Takahashi M., et al. Analysis of complex relationships between age, p53, epidermal growth factor receptor, and survival in glioblastoma patients. Cancer Res 61 (2001) 1122-1128
16. Smith J.S., Tachibana I., Passe S.M., et al. PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme. J Natl Cancer Inst 93 (2001) 1246-1256
17. Kleinschmidt-DeMasters B.K., Lillehei K.O., and Varella-Garcia M. Glioblastomas in the older old. Arch Pathol Lab Med 129 (2005) 624-631
18. Quan A.L., Barnett G.H., Lee S.Y., et al. Epidermal growth factor receptor amplification does not have prognostic significance in patients with glioblastoma multiforme. Int J Radiat Oncol Biol Phys 63 (2005) 695-703
19. McKeever P.E., Junck L., Strawderman M.S., et al. Proliferation index is related to patient age in glioblastoma. Neurology 56 (2001) 1216-1218
20. Preusser M., Gelpi E., Matej R., et al. No prognostic impact of survivin expression in glioblastoma. Acta Neuropathol (Berl) 109 (2005) 534-538
21. Pelloski C.E., Mahajan A., Maor M., et al. YKL-40 expression is associated with poorer response to radiation and shorter overall survival in glioblastoma. Clin Cancer Res 11 (2005) 3326-3334
22. Mohan D.S., Suh J.H., Phan J.L., et al. Outcome in elderly patients undergoing definitive surgery and radiation therapy for supratentorial glioblastoma multiforme at a tertiary care institution. Int J Radiat Oncol Biol Phys 42 (1998) 981-987
23. Whittle I.R., Basu N., Grant R., et al. Management of patients aged >60 years with malignant glioma: good clinical status and radiotherapy determine outcome. Br J Neurosurg 16 (2002) 343-347
24. Grau J.J., and Verger E. Radiotherapy of the brain in elderly patients. Pro Eur J Cancer 36 (2000) 443-447
25. Legler J.M., Gloeckler Ries L.A., Smith M.A., et al. Response: re: brain and other central nervous system cancers: recent trends in incidence and mortality. J Natl Cancer Inst 91 (1999) 2050A-22051
26. Pietila T.A., Stendel R., Hassler W.E., et al. Brain tumor surgery in geriatric patients: a critical analysis in 44 patients over 80 years. Surg Neurol 52 (1999) 259-263 [discussion 263-254]
27. Kelly P.J., and Hunt C. The limited value of cytoreductive surgery in elderly patients with malignant gliomas. Neurosurgery 34 (1994) 62-66 [discussion 66-67]
28. Pierga J.Y., Hoang-Xuan K., Feuvret L., et al. Treatment of malignant gliomas in the elderly. J Neurooncol 43 (1999) 187-193
29. Chang E.L., Yi W., Allen P.K., et al. Hypofractionated radiotherapy for elderly or younger low-performance status glioblastoma patients: outcome and prognostic factors. Int J Radiat Oncol Biol Phys 56 (2003) 519-528
30. Hoegler D.B., and Davey P. A prospective study of short course radiotherapy in elderly patients with malignant glioma. J Neurooncol 33 (1997) 201-204
31. Meckling S., Dold O., Forsyth P.A., et al. Malignant supratentorial glioma in the elderly: is radiotherapy useful?. Neurology 47 (1996) 901-905
32. Vuorinen V., Hinkka S., Farkkila M., and Jaaskelainen J. Debulking or biopsy of malignant glioma in elderly people-a randomised study. Acta Neurochir (Wien) 145 (2003) 5-10
33. Bauman G.S., Gaspar L.E., Fisher B.J., et al. A prospective study of short-course radiotherapy in poor prognosis glioblastoma multiforme. Int J Radiat Oncol Biol Phys 29 (1994) 835-839
34. Thomas R., James N., Guerrero D., et al. Hypofractionated radiotherapy as palliative treatment in poor prognosis patients with high grade glioma. Radiother Oncol 33 (1994) 113-116
35. Keime-Guibert F., Chinot O.L., Taillanndier L., et al. Phase III study comparing radiotherapy with supportive care in older patients with newly diagnosed anaplastic astrocyotmas (AA) og glioblastoma multiforme (GBM): an ANOCEF group trial. Neurooncology 7 (2005) 349
36. Marijnen C.A., van den Berg S.M., van Duinen S.G., et al. Radiotherapy is effective in patients with glioblastoma multiforme with a limited prognosis and in patients above 70 years of age: a retrospective single institution analysis. Radiother Oncol 75 (2005) 210-216
37. Crossen J.R., Garwood D., Glatstein E., and Neuwelt E.A. Neurobehavioral sequelae of cranial irradiation in adults: a review of radiation-induced encephalopathy. J Clin Oncol 12 (1994) 627-642
38. Stylopoulos L.A., George A.E., de Leon M.J., et al. Longitudinal CT study of parenchymal brain changes in glioma survivors. AJNR Am J Neuroradiol 9 (1988) 517-522
39. Maire J.P., Coudin B., Guerin J., and Caudry M. Neuropsychologic impairment in adults with brain tumors. Am J Clin Oncol 10 (1987) 156-162
40. Asai A., Matsutani M., Kohno T., et al. Subacute brain atrophy after radiation therapy for malignant brain tumor. Cancer 63 (1989) 1962-1974
41. Brandes A.A., Rigon A., and Monfardini S. Radiotherapy of the brain in elderly patients. Contra Eur J Cancer 36 (2000) 447-451 [discussion 451-442]
42. Walker M.D., Alexander Jr. E., Hunt W.E., et al. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial. J Neurosurg 49 (1978) 333-343
43. Bleehen N.M., and Stenning S.P. A Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma. The Medical Research Council Brain Tumour Working Party. Br J Cancer 64 (1991) 769-774
44. Roa W., Brasher P.M., Bauman G., et al. Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial. J Clin Oncol 22 (2004) 1583-1588
45. Simpson J.R., Horton J., Scott C., et al. Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive Radiation Therapy Oncology Group (RTOG) clinical trials. Int J Radiat Oncol Biol Phys 26 (1993) 239-244
46. Laws E.R., Parney I.F., Huang W., et al. Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project. J Neurosurg 99 (2003) 467-473
47. Brandes A.A., and Monfardini S. The treatment of elderly patients with high-grade gliomas. Semin Oncol 30 (2003) 58-62
48. Lutterbach J., and Ostertag C. What is the appropriate radiotherapy protocol for older patients with newly diagnosed glioblastoma?. J Clin Oncol 23 (2005) 2869-2870
49. Yuen G.J. Altered pharmacokinetics in the elderly. Clin Geriatr Med 6 (1990) 257-267
50. Baker S.D., and Grochow L.B. Pharmacology of cancer chemotherapy in the older person. Clin Geriatr Med 13 (1997) 169-183
51. Vestal R.E. Aging and pharmacology. Cancer 80 (1997) 1302-1310
52. Baraldi-Junkins C.A., Beck A.C., and Rothstein G. Hematopoiesis and cytokines. Relevance to cancer and aging. Hematol Oncol Clin North Am 14 (2000) 45-61 [viii]
53. Crawford J., Dale D.C., and Lyman G.H. Chemotherapy-induced neutropenia: risks, consequences, and new directions for its management. Cancer 100 (2004) 228-237
54. Wasil T., and Lichtman S.M. Clinical pharmacology issues relevant to the dosing and toxicity of chemotherapy drugs in the elderly. Oncologist 10 (2005) 602-612
55. Stewart L.A. Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials. Lancet 359 (2002) 1011-1018
56. DeAngelis L.M., Burger P.C., Green S.B., and Cairncross J.G. Malignant glioma: who benefits from adjuvant chemotherapy?. Ann Neurol 44 (1998) 691-695
57. Rosenblum M.L., Gerosa M., Dougherty D.V., et al. Age-related chemosensitivity of stem cells from human malignant brain tumours. Lancet 1 (1982) 885-887
58. Grant R., Liang B.C., Page M.A., et al. Age influences chemotherapy response in astrocytomas. Neurology 45 (1995) 929-933
59. Gilbert M.R., Bozik M., Armstrong T.S., et al. Aggressive chemotherapy treatment of brain tumors in the elderly: results from a Phase II study. Proc Am Soc Clin Oncol (1996)
60. Chinot O.L., Barrie M., Frauger E., et al. Phase II study of temozolomide without radiotherapy in newly diagnosed glioblastoma multiforme in an elderly populations. Cancer 100 (2004) 2208-2214
61. Glantz M., Chamberlain M., Liu Q., et al. Temozolomide as an alternative to irradiation for elderly patients with newly diagnosed malignant gliomas. Cancer 97 (2003) 2262-2266
62. Brandes A.A., Pasetto L.M., Vastola F., and Monfardini S. Temozolomide in patients with high grade gliomas. Oncology 59 (2000) 181-186
63. Dinnes J., Cave C., Huang S., and Milne R. A rapid and systematic review of the effectiveness of temozolomide for the treatment of recurrent malignant glioma. Br J Cancer 86 (2002) 501-505
64. Brandes A.A. State-of-the-art treatment of high-grade brain tumors. Semin Oncol 30 (2003) 4-9
65. Brandes A.A., Vastola F., Basso U., et al. A prospective study on glioblastoma in the elderly. Cancer 97 (2003) 657-662
66. Stupp R., Mason W.P., van den Bent M.J., et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352 (2005) 987-996
67. Gorlia T., Stupp R., Eisenhauer E., et al. Clinical prognostic factors affecting survival in patients with newly diagnosed Glioblastoma Multiforme (GBM). In: Proc Am Soc Clin Oncol (2004)
68. Murray K.J., Nelson D.F., Scott C., et al. Quality-adjusted survival analysis of malignant glioma. Patients treated with twice-daily radiation (RT) and carmustine: a report of Radiation Therapy Oncology Group (RTOG) 83-02. Int J Radiat Oncol Biol Phys 31 (1995) 453-459
69. Newall J., Ransohoff J., and Kaplan B. Glioblastoma in the older patient: how long a course of radiotherapy is necessary?. J Neurooncol 6 (1988) 325-327
70. Ampil F., Fowler M., and Kim K. Intracranial astrocytoma in elderly patients. J Neurooncol 12 (1992) 125-130
71. Villa S., Vinolas N., Verger E., et al. Efficacy of radiotherapy for malignant gliomas in elderly patients. Int J Radiat Oncol Biol Phys 42 (1998) 977-980
72. Piribauer M., Fazeny-Dorner B., Rossler K., et al. Feasibility and toxicity of CCNU therapy in elderly patients with glioblastoma multiforme. Anticancer Drugs 14 (2003) 137-143
73. Muacevic A., and Kreth F.W. Quality-adjusted survival after tumor resection and/or radiation therapy for elderly patients with glioblastoma multiforme. J Neurol 250 (2003) 561-568